Cobas ampliprep/cobas TaqMan HIV-1 v2.0 assay: consequences at the cohort level. - Wikidata - awgldk - TriplyDB

Cobas ampliprep/cobas TaqMan HIV-1 v2.0 assay: consequences at the cohort level.

Cobas ampliprep/cobas TaqMan HIV-1 v2.0 assay: consequences at the cohort level.

http://www.wikidata.org/entity/Q34983777

about

Factors Associated with Low-Level Viraemia and Virological Failure: Results from the Austrian HIV Cohort Study Ability of two commercially available assays (Abbott RealTime HIV-1 and Roche Cobas AmpliPrep/Cobas TaqMan HIV-1 Version 2.0) to quantify low HIV-1 RNA Levels (<1,000 copies/milliliter): comparison with clinical samples and NIBSC working reagent for Evaluation of the NucliSens EasyQ v2.0 assay in comparison with the Roche Amplicor v1.5 and the Roche CAP/CTM HIV-1 Test v2.0 in quantification of C-clade HIV-1 in plasma Transient detectable viremia and the risk of viral rebound in patients from the Swiss HIV Cohort Study.A Single Quantifiable Viral Load Is Predictive of Virological Failure in Human Immunodeficiency Virus (HIV)-Infected Patients on Combination Antiretroviral Therapy: The Austrian HIV Cohort Study Comparative performances of HIV-1 RNA load assays at low viral load levels: results of an international collaboration.

P2860

Q28550940-50E2D212-FFB4-4ABD-B78F-6385BD8708F8 Q33703537-62D3F160-8BBA-494C-8BC5-7FDFCE333571 Q34089637-68050D50-FC45-4B3C-9045-F74D8E3C7BE6 Q35782774-B89DBE01-6425-4CDF-9F5C-D3057426BC8A Q37091685-D50EC7BE-613A-40F2-9D1D-990E605B3D69 Q37546182-47831C09-8EF2-463F-90D9-B1E047E50AC7

P2860

Cobas ampliprep/cobas TaqMan HIV-1 v2.0 assay: consequences at the cohort level.

http://www.wikidata.org/entity/Q34983777

description

2013 nî lūn-bûn

@nan

2013 թուականի Օգոստոսին հրատարակուած գիտական յօդուած

@hyw

2013 թվականի օգոստոսին հրատարակված գիտական հոդված

@hy

2013年の論文

@ja

2013年論文

@yue

2013年論文

@zh-hant

2013年論文

@zh-hk

2013年論文

@zh-mo

2013年論文

@zh-tw

2013年论文

@wuu

name

Cobas ampliprep/cobas TaqMan HIV-1 v2.0 assay: consequences at the cohort level.

@ast

Cobas ampliprep/cobas TaqMan HIV-1 v2.0 assay: consequences at the cohort level.

@en

Cobas ampliprep/cobas TaqMan HIV-1 v2.0 assay: consequences at the cohort level.

@nl

type

label

Cobas ampliprep/cobas TaqMan HIV-1 v2.0 assay: consequences at the cohort level.

@ast

Cobas ampliprep/cobas TaqMan HIV-1 v2.0 assay: consequences at the cohort level.

@en

Cobas ampliprep/cobas TaqMan HIV-1 v2.0 assay: consequences at the cohort level.

@nl

prefLabel

Cobas ampliprep/cobas TaqMan HIV-1 v2.0 assay: consequences at the cohort level.

@ast

Cobas ampliprep/cobas TaqMan HIV-1 v2.0 assay: consequences at the cohort level.

@en

Cobas ampliprep/cobas TaqMan HIV-1 v2.0 assay: consequences at the cohort level.

@nl

P1433

Q34983777-D324CA3E-98F0-4931-A304-58DCF3074CDB

P1476

Q34983777-09486C8C-586A-42A9-A72F-0EF06E988E93

P2093

Q34983777-16A65014-EDBC-42AE-9EBF-D90620D4846D

Q34983777-16C8B989-F15E-4F56-9EAE-E45606C6AE4A

Q34983777-3CAE6F65-B18B-4304-9F90-E28610AFE07A

Q34983777-596AA339-4A25-4B17-998C-4B806BD75CFE

Q34983777-8412CEC0-0C44-4524-98E7-F67939BF5DB4

Q34983777-DC600709-0FC1-451D-8B3F-5D55D2950753

P2860

Q34983777-06A9C971-5F05-4E51-8437-D1B931DC0ADC

Q34983777-14A8A8E5-F1A5-4B62-861E-7DD1E6C78CD9

Q34983777-20A76DC4-3DD4-4D2E-A03F-066E68977AFD

Q34983777-218DA3DE-6F4F-4194-9A9D-C28362918703

Q34983777-27B4708F-0D88-43AF-97BD-013BF308AD07

Q34983777-2D3BA8E4-AA4F-4310-9CF6-4AE60F091B2B

Q34983777-4DB98022-26C7-4252-B24A-2415379E6ADF

Q34983777-4F7F0C96-28EE-4B94-A81B-A637194AD4C6

Q34983777-5FFEB7ED-A4B4-462A-A3F7-27B5DCC94FB5

Q34983777-62405435-FFF6-4E5A-B736-F1EA197A1BFD

P304

Q34983777-747D07B1-8308-41A6-8B4E-35ED255D00D7

P31

Q34983777-2D3898A8-830D-44A8-946E-2DE4EB9F1D8C

P356

Q34983777-AC360599-F6DA-4B37-865E-4B91FAC44403

P407

Q34983777-4F093D71-1D18-41E8-A433-ECC10CCCE018

P433

Q34983777-58D8A9A5-7300-40B1-93D0-59F0681F716F

P478

Q34983777-4FDFE9A3-A26E-4AB9-8B0F-82D9AA6D42B0

P50

Q34983777-A3C06001-D6F6-4C26-B3E0-7D898479A2AB

Q34983777-F85E0251-AA92-4C62-96B1-2B14FF7419ED

P577

Q34983777-7936F1DC-8AF0-46FF-B644-641F41E7AD2C

P5875

Q34983777-3C525498-BEA9-4854-AB8E-E9B324B0C8C9

P698

Q34983777-322AC33F-0395-41AC-A84F-2968B9523896

P932

Q34983777-D2C55311-2BE1-4C14-A377-94AB7850EEE9

P356

JOURNAL.PONE.0074024

P1433

P1476

Cobas ampliprep/cobas TaqMan HIV-1 v2.0 assay: consequences at the cohort level.

@en

P2093

Armin Rieger

http://www.w3.org/2001/XMLSchema#string

Bruno Ledergerber

http://www.w3.org/2001/XMLSchema#string

Hannes Oberkofler

http://www.w3.org/2001/XMLSchema#string

Katharina Grabmeier-Pfistershammer

http://www.w3.org/2001/XMLSchema#string

Ninon Taylor

http://www.w3.org/2001/XMLSchema#string

Richard Greil

http://www.w3.org/2001/XMLSchema#string

P2860

Cost ramifications of increased reporting of detectable plasma HIV-1 RNA levels by the Roche COBAS AmpliPrep/COBAS TaqMan HIV-1 version 1.0 viral load test.

HIV-1 low-level viraemia assessed with 3 commercial real-time PCR assays show high variability.

Plasma viral load and CD4+ lymphocytes as prognostic markers of HIV-1 infection.

Magnitude of virologic blips is associated with a higher risk for virologic rebound in HIV-infected individuals: a recurrent events analysis.

Single-point mutations causing more than 100-fold underestimation of human immunodeficiency virus type 1 (HIV-1) load with the Cobas TaqMan HIV-1 real-time PCR assay.

Impact of discrepancies between the Abbott realtime and cobas TaqMan assays for quantification of human immunodeficiency virus type 1 group M non-B subtypes.

Overestimation of human immunodeficiency virus type 1 load caused by the presence of cells in plasma from plasma preparation tubes

Update on HIV-1 viral load blips.

Comparison of the LCx human immunodeficiency virus (HIV) RNA quantitative, RealTime HIV, and COBAS AmpliPrep-COBAS TaqMan assays for quantitation of HIV type 1 RNA in plasma.

HIV-1 load comparison using four commercial real-time assays

P304

e74024

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1371/JOURNAL.PONE.0074024

http://www.w3.org/2001/XMLSchema#string

P407

P433

8

http://www.w3.org/2001/XMLSchema#string

P478

8

http://www.w3.org/2001/XMLSchema#string

P50

Katharina Grabmeier-Pfistershammer

P577

2013-08-30T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

256491536

http://www.w3.org/2001/XMLSchema#string

P698

24023696

http://www.w3.org/2001/XMLSchema#string

P932

3758316

http://www.w3.org/2001/XMLSchema#string